Annual Accounts Payable
$1.71 M
-$93.10 K-5.15%
December 1, 2023
Summary
- As of February 26, 2025, PTPI annual accounts payable is $1.71 million, with the most recent change of -$93.10 thousand (-5.15%) on December 1, 2023.
- During the last 3 years, PTPI annual accounts payable has fallen by -$3.90 million (-69.46%).
- PTPI annual accounts payable is now -69.46% below its all-time high of $5.61 million, reached on December 31, 2020.
Performance
PTPI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.60 M
+$809.90 K+102.38%
September 1, 2024
Summary
- As of February 26, 2025, PTPI quarterly accounts payable is $1.60 million, with the most recent change of +$809.90 thousand (+102.38%) on September 1, 2024.
- Over the past year, PTPI quarterly accounts payable has stayed the same.
- PTPI quarterly accounts payable is now -71.46% below its all-time high of $5.61 million, reached on December 31, 2020.
Performance
PTPI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PTPI Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.2% | 0.0% |
| 3 y3 years | -69.5% | -13.8% |
| 5 y5 years | -54.6% | -13.8% |
PTPI Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.4% | at low | -64.9% | +102.4% |
| 5 y | 5-year | -69.5% | at low | -71.5% | +102.4% |
| alltime | all time | -69.5% | at low | -71.5% | +102.4% |
Petros Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.60 M(+102.4%) |
| Jun 2024 | - | $791.10 K(-63.0%) |
| Mar 2024 | - | $2.14 M(+24.7%) |
| Dec 2023 | $1.71 M(-5.2%) | $1.71 M(+26.4%) |
| Sep 2023 | - | $1.36 M(-24.0%) |
| Jun 2023 | - | $1.78 M(-4.0%) |
| Mar 2023 | - | $1.86 M(+2.9%) |
| Dec 2022 | $1.81 M | $1.81 M(-13.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $2.08 M(+9.5%) |
| Jun 2022 | - | $1.90 M(-48.5%) |
| Mar 2022 | - | $3.70 M(-18.8%) |
| Dec 2021 | $4.56 M(-18.7%) | $4.56 M(-14.2%) |
| Sep 2021 | - | $5.31 M(+104.5%) |
| Jun 2021 | - | $2.60 M(-50.8%) |
| Mar 2021 | - | $5.28 M(-5.9%) |
| Dec 2020 | $5.61 M(+48.5%) | $5.61 M |
| Dec 2019 | $3.78 M | - |
FAQ
- What is Petros Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals annual accounts payable year-on-year change?
- What is Petros Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals quarterly accounts payable year-on-year change?
What is Petros Pharmaceuticals annual accounts payable?
The current annual accounts payable of PTPI is $1.71 M
What is the all time high annual accounts payable for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high annual accounts payable is $5.61 M
What is Petros Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, PTPI annual accounts payable has changed by -$93.10 K (-5.15%)
What is Petros Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of PTPI is $1.60 M
What is the all time high quarterly accounts payable for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high quarterly accounts payable is $5.61 M
What is Petros Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, PTPI quarterly accounts payable has changed by $0.00 (0.00%)